Shenzhen Grandbay-Bio Development Consulting Co., Ltd. (hereinafter referred to as "Grandbay Bio") was co-founded by the team of Dr. Tian Yuan, the founder and chairman of the Yabuli China Entrepreneur Forum, and the team of Dr. Zhang Dan, the founder of Kunling Medicine and a foreign academician of the Russian Academy of Engineering. ICH (International Coordination Conference for Human Drug Registration Technology) Biomedical Park Operation and Management Company. ...
The eighth "Xingwanhui & ICH Salon Activity's ICH Guiding Principles Implementation Promotion Conference Offline Learning Activity" was carried out smoothly.
The seventh issue of "Tax Compliance, Tax Reduction and Fee Reduction" of Xingwanhui & ICH Salon was successfully held in Haikexing Strategic Emerging Industrial Park, No. 16 Baoshan Road, Pingshan District.
The sixth issue of Xingwanhui & ICH Salon "Equity Structure Design, Equity Incentives, and Personalized Charter Design" was successfully held in the Zhongcheng Collaborative Innovation Center of Shencheng Investment & Zhongcheng Life Science Park in Pingshan District.
In order to further empower biomedical companies, focus on innovation to drive the high-quality development of the pharmaceutical industry. Thinking and Prospects on the Innovation and Development of Pharmaceutical Technology in the New Era
Innovation is the first driving force for development, and protecting intellectual property rights means protecting innovation. In order to further strengthen the protection and management of intellectual property rights of biomedical enterprises in Pingshan District, and enhance their innovation capabilities and core competitiveness.
On the afternoon of March 24, under the guidance of Shenzhen Pingshan District Science and Technology Innovation Bureau, sponsored by Shenzhen Xingwan Biomedical Development Consulting Co., Ltd., Shenzhen Pingshan High-level Talent Association, China Shenzhen (Shenzhen) Environmental Technology Co., Ltd. The third phase of Xingwanhui & ICH Salon co-organized by Fubao Eastern Investment Development Co., Ltd. was successfully held in Pingshan District Biomedical Innovation Industrial Park。
On the afternoon of March 18, the “Scientific Name” Medicine Collection of the second phase of Xingwanhui & ICH Salon sponsored by Shenzhen Xingwan Biomedicine Development Consulting Co., Ltd. and co-organized by Southern University of Science and Technology Pingshan Biomedical Research Institute | "The World" was successfully held in the conference room of the Pingshan Institute of Biomedicine, Southern University of Science and Technology.
On the afternoon of March 11, the first event of Xingwanhui & ICH Salon series was held in Pingshan District. Chen Zhu, chairman of the Pingshan District Political Consultative Conference, was in charge of the District Science and Innovation Bureau, District Investment Service Promotion Agency, Nanke Dapingshan Pharmaceutical Research Institute, and the district biomedical companies. People, conducted in-depth discussions on the development of new drugs and the construction of biomedical parks under the latest ICH guidelines.
On November 19, the "2020 Shenzhen International Biomedical Industry Innovation and Development Conference" was opened at the Yanzihu International Convention and Exhibition Center in Pingshan District, and the Shenzhen International Bio/Life Health Industry Exhibition was held concurrently.
Recently, the Russian Academy of Engineering announced the list of new academicians in 2020. Zhang Dan, the founder of Fangen Pharmaceutical, the chief strategy officer of Kunling Medicine, and the chief scientist of Shenzhen Xingwan Biomedical Development Consulting Co., Ltd., and Ph.D. were elected as foreign academicians of the Russian Academy of Engineering.
Under the influence of the new crown pneumonia, China's major health industry has become the most concerned area of the market, and it will also become the most abundant area of companies with a market value of 100 billion in the future. In 2020, the global new crown epidemic will be severe. However, in the entire health sector, venture capital funds have grown substantially, indicating that the world has paid more attention to investment in the health sector in the context of the epidemic.